超越迈凯利斯-门登:一个修改的酶动力学方程改善了药物代谢预测在自下而上的PBPK建模
Junghyun Lee1, Yun Min Song2, Hwi-Yeol Yun3
1Pharmacometrics Institute for Practical Education and Training (PIPET), College of Medicine, The Catholic University of Korea, Seoul, South Korea; Department of Pharmacology, College of Medicine, The Catholic University of Korea, Seoul, South Korea.
概括
以生理学为基础的药理动力学 (PBPK) 模型通过使用修改的代谢速率方程得到了改进. 这种新方法提高了药物清除和相互作用的预测准确性,特别是当酶度高时.
科学领域:
- 药理动力学 药理动力学
- 药物新陈代谢 药物新陈代谢
- 计算生物学 计算生物学
背景情况:
- 基于生理学的药理动力学 (PBPK) 模型整合了生物参数来预测药物药理动力学.
- 传统的PBPK模型使用迈凯利斯-门 (MM) 方程,当酶度 (ET) 接近MM常数 (KM) 时,它具有局限性.
- 这种限制可能导致对药物清除和药物相互作用 (DDI) 的不准确预测.
研究的目的:
- 通过实施修改代谢速率方程来解决自下而上的PBPK预测和临床数据之间的冲突.
- 提高PBPK模型的准确性,特别是在违反MM方程假设的场景中.
- 在药物开发中扩大PBPK建模的适用性.
主要方法:
- 在PBPK建模框架内实现了修改后的代谢速率方程.
- 在静态和动态PBPK模型中比较了修改方程与传统的MM-based方法的性能.
- 在MM方程假设无效的场景中评估预测准确性.
主要成果:
- 修改后的代谢速率方程仍然有效,即使ET与KM相比.
- 修改后的方程在动态PBPK建模中,与基于MM的方法相比,表现优越.
- 观察到清除和DDI的预测准确度有所提高,特别是在违反MM假设的条件下.
结论:
- 修改后的代谢速率方程为PBPK建模提供了比传统的MM方程更强大的方法.
- 这一进步提高了PBPK模型在预测人类药理动力学和DDI方面的准确性和实用性.
- 建议扩展指导方针,以促进药物开发中更广泛地采用修改后的方程.
相关概念视频
Nonlinear Pharmacokinetics: Michaelis-Menten Equation
1.0K
The Michaelis–Menten equation is a fundamental model for describing capacity-limited kinetics in drug metabolism. It offers insights into the rate of decline of plasma drug concentration Cp over time, with Vmax and KM as pivotal parameters.
Vmax represents the maximum achievable process rate, while KM, known as the Michaelis constant, signifies the drug concentration at which the process rate reaches half its maximum. This relationship between Vmax, KM, and Cp gives rise to three distinct...
Vmax represents the maximum achievable process rate, while KM, known as the Michaelis constant, signifies the drug concentration at which the process rate reaches half its maximum. This relationship between Vmax, KM, and Cp gives rise to three distinct...
1.0K
Determination of Michaelis Constant and Maximum Elimination Rate
437
The Michaelis constant (KM) and the theoretical maximum process rate (Vmax) are vital parameters in the Michaelis-Menten equation, central to many biochemical reactions. They provide essential insights into enzyme kinetics and drug metabolism.
These parameters can be estimated by analyzing plasma concentration data post-drug administration. A notable example of this application is phenytoin, a drug with capacity-limited kinetics. It's recommended that phenytoin should be administered at two...
These parameters can be estimated by analyzing plasma concentration data post-drug administration. A notable example of this application is phenytoin, a drug with capacity-limited kinetics. It's recommended that phenytoin should be administered at two...
437
Introduction to Enzyme Kinetics
32.5K
Enzyme kinetics studies the rates of biochemical reactions. Scientists monitor the reaction rates for a particular enzymatic reaction at various substrate concentrations. Additional trials with inhibitors or other molecules that affect the reaction rate may also be performed.
The experimenter can then plot the initial reaction rate or velocity (Vo) of a given trial against the substrate concentration ([S]) to obtain a graph of the reaction properties. For many enzymatic reactions involving a...
The experimenter can then plot the initial reaction rate or velocity (Vo) of a given trial against the substrate concentration ([S]) to obtain a graph of the reaction properties. For many enzymatic reactions involving a...
32.5K
Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance
278
Drug transporters are critical in drug absorption, distribution, and excretion processes. They should be included in physiological-based pharmacokinetic (PBPK) models, which help predict human drug disposition. However, predicting this is challenging during drug development, especially when liver transport is involved. However, with a realistic representation of body transport processes, an accurate model may be possible.
A recent model describes pravastatin's hepatobiliary excretion,...
A recent model describes pravastatin's hepatobiliary excretion,...
278
Pharmacokinetic Models: Comparison and Selection Criterion
335
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
335
Pharmacokinetic Models: Overview
1.9K
Pharmacokinetic models utilize mathematical analysis to achieve a detailed quantitative understanding of a drug's life cycle within the body. They are instrumental in simulating a drug's pharmacokinetic parameters, predicting drug concentrations over time, optimizing dosage regimens, linking concentrations with pharmacologic activity, and estimating potential toxicity.
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
1.9K


